Sarepta Therapeutics (SRPT ) PT Lowered to $90 at Morgan Stanley
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $18.02 -0.88%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT ) to $90.00 (from $93.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Nebius Group (NBIS) PT Raised to $250 at DA Davidson
- Gartner (IT) PT Lowered to $206 at BMO Capital, adjusting estimates
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
